Zalcitabine licensed in UK

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1994

Schlagwörter:	Drug Manufacturer Bold Line Information Category Zalcitabine Standard Information

Anmerkung:	© Adis International Ltd 1994

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 957(1994), 1 vom: Okt., Seite 22-22
Übergeordnetes Werk:	volume:957 ; year:1994 ; number:1 ; month:10 ; pages:22-22

Links:	Volltext

DOI / URN:	10.2165/00128413-199409570-00060

Katalog-ID:	SPR036149284

Internformat


LEADER	01000caa a22002652 4500
001	SPR036149284
003	DE-627
005	20230519193538.0
007	cr uuu---uuuuu
008	201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199409570-00060 \|2 doi
035			\|a (DE-627)SPR036149284
035			\|a (SPR)00128413-199409570-00060-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Zalcitabine licensed in UK
264		1	\|c 1994
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1994
650		4	\|a Drug Manufacturer \|7 (dpeaa)DE-He213
650		4	\|a Bold Line \|7 (dpeaa)DE-He213
650		4	\|a Information Category \|7 (dpeaa)DE-He213
650		4	\|a Zalcitabine \|7 (dpeaa)DE-He213
650		4	\|a Standard Information \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 957(1994), 1 vom: Okt., Seite 22-22 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:957 \|g year:1994 \|g number:1 \|g month:10 \|g pages:22-22
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199409570-00060 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 957 \|j 1994 \|e 1 \|c 10 \|h 22-22

Indexfelder

matchkey_str	article:22306056:1994----::actbnlc
hierarchy_sort_str	1994
publishDate	1994
allfields	10.2165/00128413-199409570-00060 doi (DE-627)SPR036149284 (SPR)00128413-199409570-00060-e DE-627 ger DE-627 rakwb eng Zalcitabine licensed in UK 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 957(1994), 1 vom: Okt., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:957 year:1994 number:1 month:10 pages:22-22 https://dx.doi.org/10.2165/00128413-199409570-00060 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 957 1994 1 10 22-22
spelling	10.2165/00128413-199409570-00060 doi (DE-627)SPR036149284 (SPR)00128413-199409570-00060-e DE-627 ger DE-627 rakwb eng Zalcitabine licensed in UK 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 957(1994), 1 vom: Okt., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:957 year:1994 number:1 month:10 pages:22-22 https://dx.doi.org/10.2165/00128413-199409570-00060 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 957 1994 1 10 22-22
allfields_unstemmed	10.2165/00128413-199409570-00060 doi (DE-627)SPR036149284 (SPR)00128413-199409570-00060-e DE-627 ger DE-627 rakwb eng Zalcitabine licensed in UK 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 957(1994), 1 vom: Okt., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:957 year:1994 number:1 month:10 pages:22-22 https://dx.doi.org/10.2165/00128413-199409570-00060 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 957 1994 1 10 22-22
allfieldsGer	10.2165/00128413-199409570-00060 doi (DE-627)SPR036149284 (SPR)00128413-199409570-00060-e DE-627 ger DE-627 rakwb eng Zalcitabine licensed in UK 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 957(1994), 1 vom: Okt., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:957 year:1994 number:1 month:10 pages:22-22 https://dx.doi.org/10.2165/00128413-199409570-00060 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 957 1994 1 10 22-22
allfieldsSound	10.2165/00128413-199409570-00060 doi (DE-627)SPR036149284 (SPR)00128413-199409570-00060-e DE-627 ger DE-627 rakwb eng Zalcitabine licensed in UK 1994 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1994 Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 957(1994), 1 vom: Okt., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:957 year:1994 number:1 month:10 pages:22-22 https://dx.doi.org/10.2165/00128413-199409570-00060 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 957 1994 1 10 22-22
language	English
source	Enthalten in Inpharma weekly 957(1994), 1 vom: Okt., Seite 22-22 volume:957 year:1994 number:1 month:10 pages:22-22
sourceStr	Enthalten in Inpharma weekly 957(1994), 1 vom: Okt., Seite 22-22 volume:957 year:1994 number:1 month:10 pages:22-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Drug Manufacturer Bold Line Information Category Zalcitabine Standard Information
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1994-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036149284
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036149284</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519193538.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199409570-00060</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036149284</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199409570-00060-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Zalcitabine licensed in UK</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1994</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Manufacturer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bold Line</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Information Category</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Zalcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Standard Information</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">957(1994), 1 vom: Okt., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:957</subfield><subfield code="g">year:1994</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199409570-00060</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">957</subfield><subfield code="j">1994</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Zalcitabine licensed in UK Drug Manufacturer (dpeaa)DE-He213 Bold Line (dpeaa)DE-He213 Information Category (dpeaa)DE-He213 Zalcitabine (dpeaa)DE-He213 Standard Information (dpeaa)DE-He213
topic	misc Drug Manufacturer misc Bold Line misc Information Category misc Zalcitabine misc Standard Information
spellingShingle	misc Drug Manufacturer misc Bold Line misc Information Category misc Zalcitabine misc Standard Information Zalcitabine licensed in UK
topic_unstemmed	misc Drug Manufacturer misc Bold Line misc Information Category misc Zalcitabine misc Standard Information
topic_browse	misc Drug Manufacturer misc Bold Line misc Information Category misc Zalcitabine misc Standard Information
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Zalcitabine licensed in UK
ctrlnum	(DE-627)SPR036149284 (SPR)00128413-199409570-00060-e
title_full	Zalcitabine licensed in UK
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1994
contenttype_str_mv	txt
container_start_page	22
container_volume	957
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199409570-00060
title_sort	zalcitabine licensed in uk
title_auth	Zalcitabine licensed in UK
abstract	© Adis International Ltd 1994
abstractGer	© Adis International Ltd 1994
abstract_unstemmed	© Adis International Ltd 1994
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Zalcitabine licensed in UK
url	https://dx.doi.org/10.2165/00128413-199409570-00060
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199409570-00060
up_date	2024-07-03T16:38:16.027Z
_version_	1803576615660158976
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036149284</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519193538.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1994 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199409570-00060</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036149284</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199409570-00060-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Zalcitabine licensed in UK</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1994</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1994</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Manufacturer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bold Line</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Information Category</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Zalcitabine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Standard Information</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">957(1994), 1 vom: Okt., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:957</subfield><subfield code="g">year:1994</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199409570-00060</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">957</subfield><subfield code="j">1994</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
score	7.3972845

Nicht das Richtige dabei?

Schreiben Sie uns!

Zalcitabine licensed in UK

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?